Skip to main content
Premium Trial:

Request an Annual Quote

Gene-IT Secures $4M in Series A Financing

NEW YORK, Nov. 30 (GenomeWeb News) - Gene-IT has secured $4.1 million through a Series A round of venture-capital financing, the company said today.


Gene-IT said it plans to use the funds to expand sales and marketing programs aimed at discovery scientists and attorneys in major markets in North America and Europe. It also will expand its flagship GenomeQuest software's capabilities to address emerging applications of sequence search in areas such as RNAi and diagnostics next year, it said.


The financing was led by Cross Atlantic Partners and Milestone Venture Partners, based in New York, with reinvestment by Paris-based Société Générale Asset Management Alternative Investments, according to Gene-IT.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.